Specific targets or changes in CTCs, such as a decrease in epithelial cell adhesion molecule (EpCAM) and the presence of cell surface vimentin, are linked to poor prognosis in patients with ESCC, underscoring their significance within the TME (155). This evidence concerns the gene EPCAM and esophageal squamous cell carcinoma.